Skip to main content
Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc. — Investor Relations & Filings

Ticker · MNMD ISIN · CA60255C8850 LEI · 549300QY8KN1O6RPFJ13 US Manufacturing
Filings indexed 437 across all filing types
Latest filing 2026-03-26 Director's Dealing
Country CA Canada
Listing US MNMD

About Mind Medicine (MindMed) Inc.

https://ir.mindmed.co/

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. The company's research and development pipeline focuses on innovative treatments derived from psychedelics and other novel compounds. These candidates, which include substances with and without acute perceptual effects, are designed to target key neurotransmitter pathways. MindMed's mission is to deliver therapies that address unmet patient needs in psychiatry, with clinical programs investigating treatments for conditions such as Major Depressive Disorder.

Recent filings

Filing Released Lang Actions
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
144 - Definium Therapeutics, Inc. (0001813814) (Subject)
Regulatory Filings
2026-03-25 English
144 - Definium Therapeutics, Inc. (0001813814) (Subject)
Regulatory Filings
2026-03-25 English
144 - Definium Therapeutics, Inc. (0001813814) (Subject)
Regulatory Filings
2026-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.